|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0120 AUD | 0.00% |
|
0.00% | -20.00% |
| 05-27 | Acrux licenses Lenzetto for Australian market for A$5.4 million | RE |
| 05-27 | Hungary's Richter and Acrux agree to license transdermal estradiol spray for Australia | RE |
| Market Cap | 6.16M 4.29M 3.78M 3.51M 3.23M 6.05M 416M 41.95M 16.36M 203M 16.12M 15.77M 704M | P/E 2024 |
-3.44x | P/E 2025 | -0.95x |
|---|---|---|---|---|---|
| Enterprise Value | 8.93M 6.23M 5.48M 5.09M 4.68M 8.77M 603M 60.83M 23.73M 294M 23.37M 22.87M 1.02B | EV / Sales 2024 |
4.09x | EV / Sales 2025 | 7.81x |
| Free-Float |
78.27% | Yield 2024 * |
-
| Yield 2025 | - |
| 22-05-22 | Acrux : Application for quotation of securities - ACR | PU |
| 22-04-13 | Acrux : Application for quotation of securities - ACR | PU |
| 22-03-15 | Acrux : Application for quotation of securities - ACR | PU |
| 22-02-24 | Acrux : Updated Board Charter | PU |
| 22-02-24 | Acrux : Application for quotation of securities - ACR | PU |
| 1 month | -14.29% | ||
| 3 months | +9.09% | ||
| 6 months | -14.29% | ||
| Current year | -20.00% |
| 1 week | 0.01 | 0.01 | |
| 1 month | 0.01 | 0.01 | |
| Current year | 0.01 | 0.02 | |
| 1 year | 0.01 | 0.02 | |
| 3 years | 0.01 | 0.1 | |
| 5 years | 0.01 | 0.14 | |
| 10 years | 0.01 | 0.84 |
| Manager | Title | Age | Since |
|---|---|---|---|
John Warmbrunn
CEO | Chief Executive Officer | - | 2025-05-31 |
Joanna Johnson
DFI | Director of Finance/CFO | - | 2021-06-20 |
| Chief Tech/Sci/R&D Officer | - | 2015-02-14 |
| Director | Title | Age | Since |
|---|---|---|---|
Ross Dobinson
CHM | Chairman | 74 | 2005-12-31 |
Timothy Oldham
BRD | Director/Board Member | - | 2013-09-30 |
Geoff Brooke
BRD | Director/Board Member | 70 | 2016-05-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| 0.00% | 0.00% | -40.00% | -76.00% | 4.29M | ||
| -0.66% | +0.44% | +14.72% | +76.40% | 48.41B | ||
| +2.20% | +1.41% | +61.04% | +111.43% | 34.99B | ||
| +1.26% | -0.57% | -5.20% | +34.48% | 11.62B | ||
| -0.46% | -3.06% | +14.15% | +80.63% | 11.47B | ||
| -1.12% | -0.19% | +36.83% | +136.73% | 8.99B | ||
| +1.52% | +0.39% | +48.79% | -5.82% | 6.88B | ||
| -0.09% | -2.84% | +13.23% | +30.57% | 6.62B | ||
| -0.59% | -1.95% | +2.23% | +178.07% | 6.43B | ||
| +1.60% | -15.49% | -29.66% | +8.47% | 5.75B | ||
| Average | +0.37% | -1.69% | +11.61% | +57.49% | 14.12B | |
| Weighted average by Cap. | +0.42% | -1.08% | +25.13% | +81.52% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 5.09M 3.55M 3.12M 2.9M 2.67M 5M 344M 34.67M 13.52M 168M 13.32M 13.04M 582M | 1.19M 830K 730K 678K 623K 1.17M 80.34M 8.11M 3.16M 39.18M 3.11M 3.05M 136M |
| Net income | -5.8M -4.04M -3.56M -3.3M -3.04M -5.7M -392M -39.5M -15.41M -191M -15.18M -14.85M -663M | -5.94M -4.14M -3.64M -3.39M -3.11M -5.84M -401M -40.49M -15.79M -196M -15.56M -15.22M -679M |
| Net Debt | 759K 529K 465K 432K 398K 746K 51.24M 5.17M 2.02M 24.99M 1.99M 1.94M 86.71M | 2.77M 1.93M 1.7M 1.58M 1.45M 2.72M 187M 18.88M 7.36M 91.28M 7.25M 7.1M 317M |
Employees
43
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-24 | A$0.0120 | 0.00% | 30,408 |
| 26-07-23 | A$0.0120 | 0.00% | 111,592 |
| 26-07-22 | A$0.0120 | 0.00% | 339 |
| 26-07-21 | A$0.0120 | 0.00% | 700,000 |
| 26-07-20 | A$0.0120 | 0.00% | 250,000 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ACR Stock
Select your edition
All financial news and data tailored to specific country editions
















